Drug reaction with eosinophilia and systemic symptoms in patients hospitalized with COVID-19: a case series from a large US healthcare system

Br J Dermatol. 2022 Oct;187(4):619-622. doi: 10.1111/bjd.21706. Epub 2022 Jul 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19*
  • Delivery of Health Care
  • Drug Hypersensitivity Syndrome* / diagnosis
  • Drug Hypersensitivity Syndrome* / etiology
  • Eosinophilia* / chemically induced
  • Humans